Curaleaf (OTCMKTS:CURLF) Issues Earnings Results

Curaleaf (OTCMKTS:CURLF) announced its quarterly earnings data on Wednesday. The company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01, Zacks reports. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%.

Curaleaf Price Performance

Curaleaf stock opened at $2.85 on Thursday. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The company has a market capitalization of $1.92 billion, a PE ratio of -8.91 and a beta of 0.71. Curaleaf has a one year low of $0.68 and a one year high of $3.65. The business has a 50 day simple moving average of $2.88 and a 200 day simple moving average of $1.83.

Wall Street Analysts Forecast Growth

CURLF has been the topic of several recent research reports. Cormark raised Curaleaf from a “hold” rating to a “moderate buy” rating in a report on Friday, August 8th. Canaccord Genuity Group raised Curaleaf to a “strong-buy” rating in a report on Thursday, October 9th. Two research analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, Curaleaf presently has a consensus rating of “Strong Buy”.

About Curaleaf

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.